ArticleFrontiers in medicine2025
Prognostic value of TAPSE in patients with septic cardiomyopathy: a retrospective observational cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of Pyroptosis in Exacerbating Sepsis-Induced Myocardial Injury: Mechanisms and Implications.Journal of inflammation research · 2026Review
- From Fluid Responsiveness to Prognosis: The Emerging Role of Point-of-Care Echocardiography in Sepsis.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Septic cardiomyopathy is an acute myocardial injury caused by sepsis with high mortality. Tricuspid annular plane systolic excursion (TAPSE) is an important parameter for evaluating right ventricular systolic function, but its relationship with prognosis in septic cardiomyopathy has not been clearly elucidated. Methods: This retrospective cohort study included 93 patients diagnosed with septic cardiomyopathy admitted to the intensive care unit (ICU). All patients underwent TAPSE measurements within 24 h of admission and were divided into abnormal (TAPSE < 1.6 cm, Results: Among the 93 patients, 25 (26.8%) died within 28 days after ICU admission. The mean TAPSE value in non-survivors was significantly lower than in survivors (1.24 ± 0.21 vs. 1.72 ± 0.20 cm, Conclusion: TAPSE is independently associated with 28-day mortality in patients with septic cardiomyopathy and can serve as a valuable indicator for assessing short-term prognosis in these patients. Incorporating TAPSE assessment into routine examinations for septic cardiomyopathy patients may assist in identifying high-risk patients early for clinical monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.